• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.20% Nasdaq Up 0.08%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    0.91 Down 0.06(5.98%) 12:42PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.97
    Open:0.97
    Bid:0.91 x 500
    Ask:0.92 x 3300
    1y Target Est:1.50
    Beta:0.89
    Next Earnings Date:N/A
    Day's Range:0.90 - 0.97
    52wk Range:0.61 - 2.00
    Volume:274,273
    Avg Vol (3m):353,242
    Market Cap:47.12M
    P/E (ttm):N/A
    EPS (ttm):-1.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AVEO

    Comparison

    Symbol% ChgMkt Cap
    AVEODown 5.98%47.12M
    AMGNUp 0.04%121.62B
    PFEUp 0.80%206.10B
    RHHBYUp 0.45%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.73
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.96
    Quarterly EPS Est (Dec-14) :-0.21
    Mean Recommendation*:4.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback